Summary
73 / 100 · Bulios Score
What speaks for it
- It earns 28 USD a year on every 100 USD of invested capital.
- The share price is below the Bulios Fair Price.
- It bought back its own shares for $401.0M in the last fiscal year, 11% of its market value.
- Out of every 100 USD of revenue, 11 USD is left as net profit.
What to watch
- Revenue fell by 1.2% a year over the last 3 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapPrice against the Bulios Fair Price
P/E against its own last 5 years
P/E against the industry (Specialty Retail)
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 4.5 USD for 1 USD of yearly profit. Over the last five years it was 10.6 USD on average.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 2.5% a year over 5 years. Over the last 3 years it fell by 1.2% a year. For the next fiscal year analysts expect revenue to fall by 2.6%. Earnings per share fell by 3.6% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 56 USD
- Sales and administration 27 USD
- Taxes and other 5.9 USD
- Net profit 11 USD
Net profit, industry median (Specialty Retail) 32 USD
Out of every 100 USD of revenue, 11 USD is left as net profit.
Profitability in detailIs it financially healthy?
MostlyRepaying all its debt would take 5.2 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
High, safe- Yield
- 4.59%
- Paid out of profit
- 21%
You receive $0.80 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Neutral- Buy 10
- Hold 11
- Sell 1
Today's price within the analysts' price targets
The average target of $21.17 is 22% above today's price. 45% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2020By product
- Bath & Body Works 54%
- Victoria's Secret 46%
By region
- Bath & Body Works International 100%
Bath & Body Works brings in 54% of revenue.
Segments in detail